NIM
RLAY icon

NEOS Investment Management’s Relay Therapeutics RLAY Stock Holding History

NEOS Investment Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113,230
Closed -$958K – 642
2025
Q4 		$958K Buy
113,230
+19,765
+21% +$141K 0.01% 558
2025
Q3 		$488K Sell
93,465
-3,685
-4% -$14.1K ﹤0.01% 579
2025
Q2 		$336K Buy
97,150
+8,040
+9% +$23.9K ﹤0.01% 576
2025
Q1 		$233K Buy
89,110
+24,455
+38% +$95.8K ﹤0.01% 576
2024
Q4 		$266K Buy
64,655
+6,365
+11% +$34.6K 0.01% 562
2024
Q3 		$413K Buy
58,290
+3,685
+7% +$27.5K 0.01% 515
2024
Q2 		$356K Buy
54,605
+31,825
+140% +$217K 0.01% 505
2024
Q1 		$189K Buy
22,780
+670
+3% +$6.54K 0.01% 555
2023
Q4 		$243K Buy
+22,110
New +$187K 0.02% 453

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

NEOS Investment Management's RLAY Position: Q1 2026 in Review

NEOS Investment Management sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 113,230 shares — an estimated $958K sold.

NEOS Investment Management first reported a position in RLAY in Q4 2023 and held it in 9 quarters. The position peaked at $958K in Q4 2025. 244 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • NEOS Investment Management reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 113,230 Relay Therapeutics shares in Q1 2026, an estimated $958K.
  • NEOS Investment Management first reported a position in Relay Therapeutics in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's Relay Therapeutics position peaked at $958K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.